The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Utility of esophageal stenting for esophageal cancer patients with dysphagia undergoing neoadjuvant therapy.
Russell E. Brown
Disclosure not yet available
Charles R. St. Hill
Disclosure not yet available
Matthew M. Harkenrider
Disclosure not yet available
Susan Ellis
Disclosure not yet available
Vivek R. Sharma
Disclosure not yet available
Moataz N. El-Ghamry
Disclosure not yet available
Charles R. Scoggins
Disclosure not yet available
Kelly M. McMasters
Disclosure not yet available
Abbas E. Abbas
Disclosure not yet available
Robert C. G. Martin
Disclosure not yet available